{"schema_version":"secwatch.filing_event.v1","accession":"0001818331-26-000005","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.313750+00:00","generated_at":"2026-05-16T10:55:57.929605+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"GeneDx prelim FY2025 rev $427M (+41%); FY2026 guidance $540-555M","bullets":["FY2025 exome/genome revenue ~$360M (+54% YoY); Q4 $104M (+32% YoY).","Exome/genome volume 97,271 (+30.5%) for FY2025; Q4 volume up 34.3%.","Adjusted gross margin 71% in Q4 and FY2025; cash & equivalents $172M.","FY2026 guidance: rev $540-555M, 33-35% exome/genome growth, adj gross margin ≥70%.","Expects positive adjusted net income in FY2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001818331-26-000005","json":"https://secwatch.observer/filing/0001818331-26-000005.json","markdown":"https://secwatch.observer/filing/0001818331-26-000005.md","text":"https://secwatch.observer/filing/0001818331-26-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000181833126000005/0001818331-26-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000181833126000005/wgs-20260112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:55:57.929605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}